Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE rejects Roche’s Ocrevus in primary progressive multiple sclerosis

September 10, 2018
Sales and Marketing NICE, Ocrevus, Roche, UK, multiple sclerosis, pharma

Of the 100,000 MS patients in England, around one in eight have the primary progressive form (PPMS), which brings debilitating …

News
nhs_sign

UK Government to invest £200m in IT and technology boost for NHS

September 7, 2018
Medical Communications, Sales and Marketing AI, Matt Hancock, NHS, NHS expo, pharma

The UK Government has lifted the curtain on plans invest more than £200 million to leverage innovations in technology and …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 7, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, MHRA, Trump, brexit, research, scandal, top 10

Brexit took the top two spots this week after it was revealed that the EMA has awarded Britain’s MHRA just …

News
canadian-flag-1229484_960_720

BC Liberal criticises opioid lawsuit for focusing too heavily on drugmakers

September 7, 2018
Medical Communications

The British Columbia Liberal opposition Critic for Mental Health and Addictions has tweeted that the lawsuits seeking damages from pharmaceutical …

News
gilead-sciences

Gilead and Galapagos’ ankylosing spondylitis drug hits Phase 2 trial goal

September 7, 2018
Medical Communications, Research and Development Galapagos, Gilead, ankylosing spondylitis, filgotinib, pharma

Gilead and Galapagos have announced that their jointly-developed selective JAK1 inhibitor filgotinib has met its primary endpoint in a Phase …

News
5204602349_c87b204860_z

FDA recruitment official says Trump’s policies are making hiring difficult

September 7, 2018
Medical Communications FDA, Trump, US, hiring, recruitment

Melanie Keller, Acting Associate Commissioner for Scientific and Clinical Recruitment at the US Food and Drug Administration (FDA) has said …

News
sanjay_keswani

Rheos Medicines appoints Roche Senior Vice President and R&D head as new CEO

September 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, CEO, Roche, cembridge, massachussets, rheos, sanjay keswani

The Cambridge Massachusetts-based biopharmaceutical company Rheos Medicines has appointed former Roche Senior Vice President and Global R&D Head, Dr Sanjay …

Appointment
pshezhetskiy

A rational new approach to cancer treatment

September 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, University of East Anglia, feature, pharma

Researchers at the University of East Anglia have developed a new targeted cancer therapy which utilises nanoparticles to deliver treatment …

Feature

Novartis sells key Sandoz US portfolios to Aurobindo for $1bn

September 6, 2018
Sales and Marketing Aurobindo, Novartis, Sandoz, pharma

Novartis has revealed it is to sell the dermatology and generic US oral solids portfolios of its generics arm Sandoz …

News
teva_canada_1

Teva drops MS and Huntington’s disease drug laquinimod, leaving rights to Active Biotech

September 6, 2018
Medical Communications, Research and Development Active Biotech, Laquinimod, Teva, pharma

Israeli multinational Teva Pharmaceutical has decided to discontinue the development of laquinimod. As such, all rights for the orally administered …

News
shibam_wadi_hadhramaut_yemen

WHO ship 500 tons of medicine to Yemen

September 6, 2018
Manufacturing and Production Sanaa, WHO, Yemen, middle east, sana'a, war

The World Health Organisation (WHO) has airlifted more than 500 tons of medicines to Yemen over the previous month in …

News
gsk_boronia_australia

GSK to axe 650 positions across US workforce

September 6, 2018
Manufacturing and Production GSK, GlaxoSmithKline, pharma

GlaxoSmithKline has announced its intention to cut 650 employees from its current US workforce, with the cutbacks coming as part …

News
24327909026_6435de0904_z

Ketamine’s antidepressant effects may be linked to brain’s opioid system

September 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ketamine, antidepressant, depression, mental health, opioid

Ketamine’s antidepressant effect works through the activation of the brains opioid receptors, a new study published in The American Journal …

News
jackie_fouse_hires

Agios appoints Celgene’s Jacqualyn Fouse as new CEO

September 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, COO, Celgene, Jacqualyn Fouse, agios

The Massachusetts-based oncology specialist Agios Pharmaceuticals has appointed former Celgene President and COO Jacqualyn Fouse as their new Chief Executive …

Appointment
shutterstock_206748499

FDA turns to real-world evidence to improve regulatory process

September 5, 2018
Medical Communications, Research and Development, Sales and Marketing FDA, pharma, real world data, real world evidence, real-world data, real-world evidence

The FDA has announced its intention to incorporate real-world data elements to a greater degree into its regulatory decision-making framework …

News

Puma Biotech’s breast cancer drug authorised by European Commission, despite prior concerns

September 5, 2018
Research and Development Cancer, EU, breast cancer, ec approval, puma biotechnology

Puma Biotechnology have received European Commission marketing authorisation for Nerlynx (neratinib) despite prior concerns as to the safety and efficacy …

News

Europe-wide policy could boost generics market, study suggests

September 5, 2018
Research and Development Europe, generics, growth, markets, pharma

A Europe-wide policy covering the generic pharmaceutical market would facilitate significant growth in the pharmaceutical sector according to a new …

News

Sanofi to pay $25m over Kazakhstan and Middle East corruption allegations

September 5, 2018
Research and Development Kazakhstan, SEC, Sanofi, allegations, corruption, middle east

French pharma giant Sanofi will pay more than $25 million to settle corruption charges related to their subsidiaries in Kazakhstan …

News

Novartis’ CAR T therapy Kymriah to become available on the NHS

September 5, 2018
Research and Development CAR T, CAR-T, Gilead, Kymriah, NHS, Novartis

Novartis’ Kymriah is set to become the first CAR T therapy to become available on the NHS after it was …

News
melanie_lee_770x510

UK research charity LifeArc appoints experienced leader Melanie Lee as new CEO

September 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, melanie lee

The life sciences medical research charity LifeArc, formerly MRC Technology, has appointed Dr Melanie Lee as its new Chief Executive …

Appointment
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026